For PD-L1-targeted diagnostic radiotracers, an important effort is to reduce radioactive accumulation in nontarget tissues, such as the liver, kidneys, and blood, to (1) obtain a high target-to-background ratio for PD-L1-positive tumor imaging and (2) decrease the radiation risk to the main source organs and the whole body of patients. Here, CD274 is linked to neoplasm.